The Group Room Breast Cancer Feature Interviews
recorded at the ECCO15 – 34th ESMO Multidisciplinary Conference

September 20-24, 2009 in Berlin, Germany

Vital Options International and The Group Room recorded feature interviews with noted breast oncology opinion leaders at the recent ECCO/ESMO meeting in Berlin. The discussions explored the research involving HER2-postive breast cancer and HER2+ treatment, such as the current issues regarding the use of non-cytotoxic treatment advances, with emphasis on those who are hormone receptor-positive.

Tune in to discussions with:

	José Baselga, MD, PhD - Chairman and Professor of Medicine, Vall D'Hebron Institute of Oncology in Barcelona, Spain; President of the European Society of Medical Oncology (ESMO). Prof. Baselga is also the co-author of a recent editorial on "How to Treat Hormone Receptor Positive, HER2 amplified Breast Cancer" in the September 28th online edition of the Journal of Clinical Oncology (JCO)
	Maria Paz Fernandez-Ortega, RN, Nursing Research Coordinator from the Institut Catala Oncologia in Barcelona, Spain, shared thoughts on communication strategies and issues that patients and providers deal with in Europe.
Click here to listen or download: 1. What is HER2 and Hormone Driven Cancer? How is it Detected? 2. Challenges and Treatment Options 3. Questions You Should Ask Your Physician 4. Your Oncology Nurse 5. Doctor, What are the Implications of a HER2 Positive Diagnosis? 6. Common Patient Questions 7. The Proactive Patient 8. Closing Thoughts
	C. Kent Osborne, MD, Director of the Dan L. Duncan Cancer Center at Baylor College of Medicine, and Director of the Lester & Sue Smith Breast Center in Houston, Texas, and Co-Director of the CTRC-AACR San Antonio Breast Cancer Symposium, provided us with the USA perspective and how this is relevant to patients here.
Click here to listen or download: 1. What HER2+ and Hormone-Receptor Positive Patients in the U.S. Need to Know

The Group Room is produced by VITAL OPTIONS INTERNATIONAL, a non-profit cancer communications organization. Click here to listen to archived shows and download podcasts of The Group Room.

The statements and information provided on The Group Room interviews are not intended as medical or psychological care and we urge all patients to seek medical and psychological advice and care from their own providers.

This special feature has been made possible with support from GlaxoSmithKline Oncology